Loading...
OTCM
VIVE
Market cap2kUSD
Oct 08, Last price  
0.00USD
1D
0.00%
1Q
0.00%
Jan 2017
-100.00%
Name

Viveve Medical Inc

Chart & performance

D1W1MN
OTCM:VIVE chart
P/E
—
P/S
0.00
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
35.28%
Revenues
6m
+17.28%
8,838,0008,334,0007,573,0007,636,0007,146,0006,004,0005,330,0004,711,0003,910,000671,0001,080,0001,274,00090,0001,447,0007,141,00015,288,00018,517,0006,567,0005,479,0006,426,000
Net income
-22m
L+0.51%
305,000517,000-833,000-1,268,0001,319,000-2,367,000-1,940,000-1,626,000-505,000-5,758,000-8,387,0003,499,000-6,180,000-12,426,000-20,111,000-36,630,000-49,182,000-42,526,000-21,915,000-22,027,000
CFO
-13m
L-15.47%
937,000607,0003,358,000-127,000494,000-1,803,000-2,968,000-2,373,000-1,346,000-3,393,000-3,165,000-4,804,000-5,991,000-12,195,000-18,087,000-34,853,000-43,090,000-31,236,000-15,234,000-12,878,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Viveve develops and sells healthcare-focused human resources (HR) software solutions designed to streamline and unify HR operations for healthcare organizations. It offers an all-in-one platform that supports recruitment, employee management, and attendance management, aiming to reduce administrative burden and enhance the employee experience throughout their career lifecycle. The company also provides solutions specifically tailored for the healthcare and mental and behavioral health sectors. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.

Key people

Scott Durbin
Chief Executive Officer, Director · since 2018
Jim Robbins
Senior Vice President - Finance and Administration · since 2020
Steven Basta
Independent Chairman of the Board · since 2019
Deborah Jorn
Independent Director · since 2021
Independent Director · since 2017
Independent Director · since 2020
IPO date
Mar 03, 1992
Employees
47
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFY
2021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT